4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001960048-26-000007
SVP, Finance & CAO sold 3,000 shares at $60.00 ($180,000)
- SVP, Finance & CAO acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cowan Elvia SVP, Finance & CAO | 2026-04-07 | Option exercise 10b5-1 | +3,000 | $25.92 | $77,760 | 31,975 | D |
| Cowan Elvia SVP, Finance & CAO | 2026-04-07 | Sale 10b5-1 | −3,000 | $60.00 | $180,000 | 28,975 | D |
| Derivatives | |||||||
| Cowan Elvia SVP, Finance & CAO | 2026-04-07 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 93,068 | D | ||
| Open-market sales · 3,000 sh · avg $60.00 · $180,000 | |||||||
Loading xslF345X06/wk-form4_1775680362.xml…